Showing results (241-250 of 829) with videos related to
Sort By:
Pageof 83
Analytical Chemistry|March 1, 2018
A Time-of-Flight Secondary Ion Mass Spectrometry/Multivariate Analysis (ToF-SIMS/MVA) Approach To Identify Phase Segregation in Blends of Incompatible but Extremely Similar ResinsGustavo F Trindade, Marie-Laure Abel, Chris Lowe, et al.Current Opinion in Endocrinology, Diabetes, and Obesity|December 6, 2022
Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetesNick S R Lan, Damon A Bell, Gerald F Watts, et al.Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical ExperienceClaudia Stefanutti, Dick C Chan, Serafina Di Giacomo, et al.Current Opinion in Lipidology|October 15, 2021
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutationsCraig S McIntosh, Gerald F Watts, Steve D Wilton, et al.Molecules (Basel, Switzerland)|August 12, 2023
Expanding the Efficacy of Fingermark Enhancement Using ToF-SIMSDeborah Charlton, Catia Costa, Steven J Hinder, et al.Journal of Internal Medicine|December 21, 2019
Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunitiesA Vuorio, G F Watts, W J Schneider, et al.British Heart Journal|March 1, 1995
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosisS Ye, G F Watts, S Mandalia, et al.Diabetes & Vascular Disease Research|July 30, 2010
Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patientsSandra J Hamilton, Gerard T Chew, Timothy M E Davis, et al.Clinical Science (London, England : 1979)|April 21, 2017
Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyteAllan D Sniderman, Robert Scott Kiss, Thomas Reid, et al.International Journal of Clinical Practice|January 19, 2008
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?D C Chan, M M Chen, E M M Ooi, et al.Pageof 83